- $82.27m
- $10.16m
- 25
- 51
- 75
- 48
Annual cashflow statement for Instil Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.52 | -37.7 | -157 | -223 | -156 |
| Depreciation | |||||
| Non-Cash Items | 0.843 | 6.39 | 27.5 | 46.6 | 78.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.366 | 1.48 | 4.36 | -9.57 | -9.02 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -5.29 | -29.6 | -122 | -180 | -82 |
| Capital Expenditures | -0.21 | -50.8 | -57.8 | -84.6 | -20.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.55 | -0.306 | -417 | 199 | 61.8 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.76 | -51.1 | -474 | 115 | 41.1 |
| Financing Cash Flow Items | 0 | 0.065 | -0.069 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.9 | 313 | 393 | 71.9 | 8.08 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.89 | 233 | -204 | 5.63 | -33 |